Нефропатический цистиноз. Недооцененная проблема детской нефрологии


А.Н. Цыгин, М.Ю. Каган, Н.Н. Картамышева, Н.А. Карагулян, Е.Н. Левченко

Научный центр здоровья детей, Москва; Оренбургская областная детская больница, Оренбург; госпиталь Католического университета г. Лейвена, Бельгия
В статье приводится обзор патогенеза и клиники цистиноза, приводится российский опыт его диагностики и лечения.

Литература


1. Gahl W.A., Thoene J.G., Schneider J.A. Cystinosis. N. Engl. J. Med. 2002;1347:111–121.
2. Scriver C., Beaudet A., Sly W. et al. The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill 2001;5085–5101.
3. Anikster Y., Lucero C., Guo J. et al. Ocular nonnephropathic cystinosis: clinical, biochemical, and molecular correlations. Pediatr. Res. 2000;47:17–23.
4. Broyer M., Gubler M. Cystinosis, from Oxford Textbook of Clinical Nephrology, 3rd Edition, Oxford University Press 2005;2367–2373.
5. Gahl W.A., Kaiser-Kupfer M.I. Complications of nephropathic cystinosis after renal failure. Pediatr Nephrol 1987;1:260–268.
6. Theodoropoulos D.S., Krasnewich D., Kaiser-Kupfer M.I. et al. Classic nephropathic cystinosis as an adult disease. JAMA 1993;270:2200–2204.
7. Gahl W.A. Early oral cysteamine therapy for nephropathic cystinosis. Eur. J. Pediatr. 2003;162[Suppl. 1]:S38–41.
8. Gahl W.A., Reed G.F., Thoene J.G. et al. Cysteamine therapy for children with nephropathic cystinosis. N. Engl. J. Med. 1987;316:971–977.
9. Gahl W.A., Thoene J.G., Schneider J.A. et al. Cystinosis: progress in a prototypic disease. Ann. Intern. Med. 1988;109:557–569.
10. Kimonis V.E., Troendle J., Rose S.R. et al. Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis. J. Clin. Endocrinol. Metab. 1995;80:3257–3261.
11. Kleta R., Bernardini I., Ueda M. et al. Long-term follow-up of welltreated nephropathic cystinosis patients. J. Pediatr. 2004;145:555–560.
12. Kleta R., Kaskel F., Dohil R. et al. NIH Office of Rare Diseases. First NIH/Office of Rare Diseases Conference on cystinosis: past, present, and future. Pediatr. Nephrol. 2005;20:452–454.
13. Markello T.C., Bernardini I.M., Gahl W.A. Improved renal function in children with cystinosis treated with cysteamine. N. Engl. J. Med. 1993;328:1157–1162.
14. Sonies B.C., Almajid P., Kleta R. et al. Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy. Medicine (Baltimore) 2005;84:137–146.
15. Thoene J.G. Cysteamine treatment of nephropathic cystinosis. Prog. Clin. Biol. Res. 1983;127:125–131.
16. Tsilou E.T., Rubin B.I., Reed G. et al. Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy. Ophthalmology 2006;113:1002–1009.
17. McDowell G.A., Town M.M., van’t Hoff W. et al. Clinical and molecular aspects of nephropathic cystinosis. J. Mol. Med. 1998;76:295–302.
18. Kalatzis V., Cherqui S., Antignac C. et al. Cystinosin, the protein defective in cystinosis, is a H+-driven lysosomal cystine transporter. EMBO J. 2001;20:5940–5949.
19. Town M., Jean G., Cherqui S. et al. Novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet 1998;18:319–324.
20. Shotelersuk V., Larson D., Anikster Y. et al. CTNS mutations in an Americanbased population of cystinosis patients. Am J Hum Genet 1998;63:1352–1362.
21. Kalatzis V., Antignac C. Cystinosis: from gene to disease. Nephrol. Dial. Transplant. 2002;17:1883–1886.
22. Kleta R., Anikster Y., Lucero C. et al. CTNS mutations in African American patients with cystinosis. Mol. Genet. Metab. 2001;74:332–337.
23. McGowan-Jordan J., Stoddard K., Podolsky L. et al. Molecular analysis of cystinosis: probable Irish origin of the most common French Canadian mutation. Eur. J. Hum. Genet. 1999;7:671–678.
24. Shotelersuk V., Larson D., Anikster Y. et al. CTNS mutations in an American-based population of cystinosis patients. Am. J. Hum. Genet. 1998; 63:1352–1362.
25. Thoene J., Lemons R., Anikster Y. et al. Mutations of CTNS causing intermediate cystinosis. Mol. Genet. Metab. 1999;67:283–289.
26. Gahl W.A., Bashan N., Tietze F. et al. Lysosomal cystine counter-transport in heterozygotes for cystinosis. Am. J. Hum. Genet. 1984;36:77–82.
27. Ray T.L., Tobias J.D. Perioperative care of the patient with nephropathic cystinosis. Paediatr. Anaesth. 2004;14:878–885.
28. Attard M., Jean G., Forestier L. et al. Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin. Hum Mol Genet 1999;8:2507–2514.
29. Gahl W.A., Tietze F. Lysosomal cystine transport in cystinosis variants and their parents. Pediatr. Res. 1987;21:193–196.
30. Gahl W.A. Cystinosis coming of age. Adv. Pediatr. 1986;33:95–126.
31. Middleton R., Bradbury M., Webb N. et al. Cystinosis. A clinicopathological conference. “From toddlers to twenties and beyond” Adult-Paediatric Nephrology Interface Meeting, Manchester 2001. Nephrol. Dial. Transplant. 2003;18:2492–2495.
32. Theodoropoulos D.S., Shawker T.H., Heinrichs C. et al. Medullary nephrocalcinosis in nephropathic cystinosis. Pediatr. Nephrol. 1995; 9:412–418.
33. Bernardini I., Rizzo W.B., Dalakas M. et al. Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome. J. Clin. Invest. 1985; 75:1124–1130.
34. Manz F., Gretz N. Progression of chronic renal failure in a historical group of patients with nephropathic cystinosis. European Collaborative Study on Cystinosis. Pediatr. Nephrol. 1994;8:466–447.
35. Mahoney C.P., Striker G.E. Early development of the renal lesions in infantile cystinosis. Pediatr. Nephrol. 2000;15:50–56.
36. Koizumi F., Koeda T., Wakaki K. et al. Cystinosis with marked atrophy of the kidneys and thyroid. Histological and ultrastructural studies in an autopsy case. Acta. Pathol. Jpn. 1985;35:145–155.
37. Busuttil D.P., Liu Yin J.A. The bone marrow in hereditary cystinosis. Br J Haematol 2000;111:385.
38. Tsilou E.T., Rubin B.I., Reed G.F. et al. Age-related prevalence of anterior segment complications in patients with infantile nephropathic cystinosis. Cornea 2002;21:173–176.
39. Wong V.G. Ocular manifestations in cystinosis. Birth. Defects Orig. Arctic. Ser. 1976;12:181–186.
40. Broyer M., Gubler M. Cystinosis. In: Oxford Textbook of Clinical Nephrology, 3rd Edition, Oxford University Press 2005;2367–2373.
41. Gahl W.A. Early oral cysteamine therapy for nephropathic cystinosis. Eur. J. Pediatr. 2003;162[Suppl. 1]:S38–S41.


Об авторах / Для корреспонденции


Цыгин А.Н. - зав. нефрологическим отделением Научного центра здоровья детей РАМН
E-mail : tsygin@nczd.ru;
Каган М.Ю. - зав. нефрологическим отд. Оренбургской областной детской больницы
Картамышева Н.Н. - ведуший научный сотрудник нефрологического отделения Научного центра здоровья детей РАМН
Карагулян Н.А. - врач-офтальмолог Консультативно-диагностического центра Научного центра здоровья детей РАМН
Левченко Е.Н. - зав. нефрологическим отделением госпиталя Католического университета г. Лейвена (Бельгия)


Похожие статьи


Бионика Медиа